Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / SPONSORED ADR
-
Number of holders
-
712
-
Total 13F shares, excl. options
-
278M
-
Shares change
-
+16.1M
-
Total reported value, excl. options
-
$14.9B
-
Value change
-
+$862M
-
Put/Call ratio
-
0.74
-
Number of buys
-
364
-
Number of sells
-
-244
-
Price
-
$53.48
Significant Holders of GLAXOSMITHKLINE PLC - SPONSORED ADR (GSK) as of Q2 2014
776 filings reported holding GSK - GLAXOSMITHKLINE PLC - SPONSORED ADR as of Q2 2014.
GLAXOSMITHKLINE PLC - SPONSORED ADR (GSK) has 712 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 278M shares
.
Largest 10 shareholders include Dodge & Cox (60.2M shares), ROYAL BANK OF CANADA (14M shares), Fisher Asset Management, LLC (11.4M shares), State Street Corp (10.8M shares), BANK OF AMERICA CORP /DE/ (10.8M shares), PRICE T ROWE ASSOCIATES INC /MD/ (9.04M shares), RENAISSANCE TECHNOLOGIES LLC (8.87M shares), WELLS FARGO & COMPANY/MN (8.52M shares), Allianz Asset Management AG (7.24M shares), and Bank of New York Mellon Corp (6.65M shares).
This table shows the top 712 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.